Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Techne Corp - Common Stock (NQ:TECH)

60.61 +0.27 (+0.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 Next >
Stay informed with the top movers within the S&P500 index on Wednesday.
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Illumina (ILMN) Reports Earnings Tomorrow: What To Expect
Genomics company Illumina (NASDAQ:ILMN) will be reporting results tomorrow after the bell. Here’s what investors should know. 
Via StockStory
IQVIA (IQV) Q4 Earnings Report Preview: What To Look For
Clinical research company IQVIA (NYSE: IQV) will be announcing earnings results tomorrow before market hours. Here’s what to look for. 
Via StockStory
Earnings To Watch: Mettler-Toledo (MTD) Reports Q4 Results Tomorrow
Precision measurement company Mettler-Toledo (NYSE:MTD) will be announcing earnings results tomorrow after market close. Here’s what to expect. 
Via StockStory
Earnings Scheduled For February 5, 2025
Via Benzinga
(TECH) - Analyzing Bio-Techne's Short Interest
Via Benzinga
A Look Ahead: Bio-Techne's Earnings Forecast
Via Benzinga
Deep Dive Into Bio-Techne Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Bio-Techne (NASDAQ:TECH) Surprises With Strong Q4, Stock Soars
Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 9% year on year to $297 million. Its non-GAAP profit of $0.42 per... 
Via StockStory
Stocks Rise On Core Inflation Slowdown, Banks Rally After Strong Q4 Earnings, Treasury Yields Plummet
Major indices rallied on Wednesday after December inflation data showed underlying price pressures slowing, reducing fears of a prolonged pause in interest rate cuts by the Federal Reserve. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Markets Breathe Sigh Of Relief After In-Line Inflation Data: Stocks Rebound As Small Caps, Bonds Soar
October inflation data meets expectations with a slight uptick in annual rate, core inflation steady at 3.3%. Fed may cut rates in Dec. Market reacts positively. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Demystifying Bio-Techne: Insights From 4 Analyst Reviews
Via Benzinga
Navigating 4 Analyst Ratings For Bio-Techne
Via Benzinga
Bio-Techne: Commitment to Investor Contentment with Steadfast Earnings Performance
Via Benzinga
Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. being the worst performers. 
Via Benzinga
TECH Stock Earnings: Bio-Techne Meets EPS, Misses Revenue for Q4 2024
TECH stock results show that Bio-Techne met analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024. 
Via InvestorPlace
3 Genomics Stocks That May Transform Personalized Medicine
These are three of the best genomics stocks to buy for a lucrative entry into a specialized section of the biotech industry. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
7 Cheap Biotech Stocks With Major Upside Potential
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks. 
Via InvestorPlace
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
Thanks to the underlying pertinence, these established biotech stocks to buy offer confidence to investors facing tricky market conditions. 
Via InvestorPlace
5 Stocks At The Forefront Of S&P 500 ETF's Latest Rally
Wall Street has regained momentum in recent sessions, with the S&P 500 Index logging the fourth consecutive gain. The benchmark reclaimed the 5,200 level in the latest trading session before ending... 
Via Talk Markets
Topics ETFs Stocks
Exposures US Equities
Which Large-Cap Stocks Are Winning This Earnings Season? 15 Stocks To Watch (April 28-May 4, 2024)
Last week's top performers included Carvana, Pinterest, Moderna and JD.Com. 
Via Benzinga
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
TECH Stock Earnings: Bio-Techne Beats EPS, Beats Revenue for Q3 2024
TECH stock results show that Bio-Techne beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine. 
Via InvestorPlace
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas. 
Via InvestorPlace
Bio-Techne: Bolstering Investor Value with Reduced Dividends and Amplified Earnings
By the end of today, February 26, 2024, Bio-Techne (NASDAQ:TECH) is set to deliver a dividend payout of $0.08 per share, equating to an annualized dividend yield of 0.46%. 
Via Benzinga
The 3 Best Biotech Stocks to Buy in February 2024
The best biotech stocks to buy offer consistent growth opportunities and resist the influence of singular drug successes. 
Via InvestorPlace
RBC Capital Maintains Sector Perform Rating for Bio-Techne: Here's What You Need To Know
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.